A novel ACTB-FOSB gene fusion was identified in nearly half of pseudomyogenic hemangioendothelioma cases, expanding the spectrum of genetic alterations in this vascular neoplasm.
No takes yet. Share an insight, caveat, or question.
Extends genetic spectrum of pseudomyogenic hemangioendothelioma; leaves open diagnostic or therapeutic relevance.
Agaram et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: